[Prevention of Haemophilus influenzae type B infections: the contribution of conjugated polyosidic vaccines].
Hessel
L
L
Département médical, Institut Mérieux, Lyon, France.
D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D011134:Polysaccharides / Q000627:therapeutic use*; D011292:Premedication; D013745:Tetanus Toxoid / Q000627:therapeutic use*
D004338:Drug Combinations; D011134:Polysaccharides; D013745:Tetanus Toxoid; C008984:polyribitol phosphate
Prévention des infections à Haemophilus influenzae de type b: l'apport des vaccins polyosidiques conjugués.